X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7583) 7583
Newsletter (164) 164
Magazine Article (88) 88
Newspaper Article (16) 16
Book / eBook (4) 4
Book Chapter (4) 4
Dissertation (2) 2
Web Resource (2) 2
Book Review (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6815) 6815
science & technology (4321) 4321
life sciences & biomedicine (4033) 4033
male (3609) 3609
female (3437) 3437
antitubercular agents - therapeutic use (3393) 3393
antitubercular agents - adverse effects (3389) 3389
tuberculosis (3136) 3136
adult (2956) 2956
middle aged (2318) 2318
tuberculosis, pulmonary - drug therapy (1807) 1807
tuberculosis - drug therapy (1487) 1487
antitubercular agents (1351) 1351
aged (1342) 1342
infectious diseases (1291) 1291
antitubercular agents - administration & dosage (1270) 1270
treatment outcome (1268) 1268
adolescent (1080) 1080
drug therapy, combination (1054) 1054
drug therapy (951) 951
risk factors (896) 896
isoniazid - adverse effects (778) 778
tuberculosis, multidrug-resistant - drug therapy (774) 774
respiratory system (749) 749
general & internal medicine (741) 741
child (703) 703
pharmacology & pharmacy (691) 691
mycobacterium tuberculosis - drug effects (684) 684
retrospective studies (680) 680
young adult (679) 679
isoniazid - therapeutic use (656) 656
anti-bacterial agents - adverse effects (654) 654
abridged index medicus (647) 647
care and treatment (635) 635
drug resistance (614) 614
microbiology (605) 605
medicine, general & internal (587) 587
antibiotics, antitubercular (569) 569
rifampin - adverse effects (560) 560
research (549) 549
health aspects (537) 537
rifampin - therapeutic use (534) 534
isoniazid (531) 531
animals (529) 529
immunology (521) 521
antitubercular agents - pharmacology (500) 500
time factors (495) 495
analysis (491) 491
medicine (475) 475
old medline (475) 475
drugs (465) 465
mycobacterium tuberculosis (447) 447
mycobacterium tuberculosis - isolation & purification (447) 447
patients (446) 446
research article (438) 438
hiv (417) 417
rifampin - administration & dosage (409) 409
chemical and drug induced liver injury - etiology (403) 403
isoniazid - administration & dosage (396) 396
child, preschool (393) 393
aged, 80 and over (387) 387
tuberculosis - epidemiology (384) 384
infant (379) 379
dermatologic agents (378) 378
prospective studies (375) 375
hiv infections - complications (372) 372
hiv infections - drug therapy (372) 372
rifampin (372) 372
drug administration schedule (371) 371
incidence (360) 360
human immunodeficiency virus--hiv (359) 359
tuberculosis - diagnosis (357) 357
complications and side effects (350) 350
drug resistance in microorganisms (339) 339
tuberculosis, pulmonary - diagnosis (337) 337
tuberculosis - complications (336) 336
follow-up studies (328) 328
infections (321) 321
tuberculosis, pulmonary - complications (320) 320
tuberculosis - prevention & control (315) 315
drug interactions (313) 313
medical research (311) 311
dosage and administration (305) 305
diagnosis (299) 299
microbial sensitivity tests (299) 299
ethambutol - adverse effects (296) 296
mortality (280) 280
science & technology - other topics (270) 270
pyrazinamide - adverse effects (269) 269
public health (268) 268
ethambutol - therapeutic use (265) 265
multidisciplinary sciences (264) 264
sputum - microbiology (264) 264
tuberculosis, pulmonary - microbiology (256) 256
science (253) 253
aids/hiv (247) 247
aids-related opportunistic infections - drug therapy (245) 245
clinical trials (245) 245
infectious disease (245) 245
antitubercular agents - pharmacokinetics (244) 244
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6346) 6346
Russian (404) 404
French (334) 334
German (309) 309
Japanese (195) 195
Spanish (139) 139
Italian (104) 104
Portuguese (89) 89
Polish (73) 73
Chinese (60) 60
Romanian (27) 27
Dutch (20) 20
Swedish (14) 14
Croatian (12) 12
Czech (12) 12
Danish (12) 12
Norwegian (9) 9
Korean (7) 7
Hebrew (5) 5
Turkish (5) 5
Ukrainian (5) 5
Bulgarian (3) 3
Hungarian (3) 3
Slovak (3) 3
Serbian (2) 2
Bosnian (1) 1
Finnish (1) 1
Greek (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Archives of Dermatological Research, ISSN 0340-3696, 1/2009, Volume 301, Issue 1, pp. 99 - 105
Drug-induced lupus erythematosus (DILE) is defined as a lupus-like syndrome temporally related to continuous drug exposure which resolves after discontinuation... 
Drug-induced lupus erythematosus | Antinuclear antibodies (ANA) | Medicine & Public Health | Dermatology | Anti-TNFα-induced lupus | Anti-histone antibodies | Subacute cutaneous drug-induced lupus (SCLE) | Drug reactions | Life Sciences & Biomedicine | Science & Technology | Antifungal Agents - adverse effects | Antitubercular Agents - adverse effects | Naphthalenes - adverse effects | Antibodies - metabolism | Calcium Channel Blockers - adverse effects | Serositis | Exanthema | Humans | Isoniazid - adverse effects | Interferons - adverse effects | Antihypertensive Agents - administration & dosage | Sodium Chloride Symporter Inhibitors - adverse effects | Arthritis | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Lupus Erythematosus, Systemic - immunology | Sodium Chloride Symporter Inhibitors - administration & dosage | Tumor Necrosis Factor-alpha - immunology | Antibodies - immunology | Lupus Erythematosus, Cutaneous - chemically induced | Procainamide - administration & dosage | Lupus Erythematosus, Cutaneous - immunology | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Anti-Arrhythmia Agents - administration & dosage | Procainamide - adverse effects | Antihypertensive Agents - adverse effects | Hydralazine - adverse effects | Isoniazid - administration & dosage | Lupus Erythematosus, Systemic - diagnosis | Interferons - administration & dosage | Hydralazine - administration & dosage | Animals | Anti-Arrhythmia Agents - adverse effects | Naphthalenes - administration & dosage | Calcium Channel Blockers - administration & dosage | Antitubercular Agents - administration & dosage | Lupus Erythematosus, Systemic - chemically induced | Antifungal Agents - administration & dosage | Lupus Erythematosus, Cutaneous - diagnosis | Lupus | Antigen-antibody reactions | Enzymes | Antigens | Biological products | Antibodies | Viral antibodies | Enzyme inhibitors | Systemic lupus erythematosus | Fluocinolone acetonide | Calcium channel blockers | Diuretics | Kidney diseases | Hydralazine | Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2013, Volume 13, Issue 1, pp. 27 - 35
Journal Article
by Danel, Christine and Moh, Raoul and Gabillard, Delphine and Badje, Anani and Le Carrou, Jérôme and Ouassa, Timothée and Ouattara, Eric and Anzian, Amani and Ntakpé, Jean-Baptiste and Minga, Albert and Kouame, Gérard M and Bouhoussou, Franck and Emieme, Arlette and Kouamé, Antoine and Inwoley, André and Toni, Thomas-D'Aquin and Ahiboh, Hugues and Kabran, Mathieu and Rabe, Cyprien and Sidibé, Baba and Nzunetu, Gustave and Konan, Romuald and Gnokoro, Joachim and Gouesse, Patrice and Messou, Eugène and Dohoun, Lambert and Kamagate, Synali and Yao, Abo and Amon, Solange and Kouame, Amadou-Barenson and Koua, Aboli and Kouamé, Emmanuel and Ndri, Yao and Ba-Gomis, Olivier and Daligou, Marcelle and Ackoundzé, Simplice and Hawerlander, Denise and Ani, Alex and Dembéle, Fassery and Koné, Fatoumata and Guéhi, Calixte and Kanga, Constance and Koule, Serge and Séri, Jonas and Oyebi, Mykayila and Mbakop, Nathalie and Makaila, Olewole and Babatunde, Carole and Babatounde, Nathanael and Bleoué, Gisèle and Tchoutedjem, Mireille and Kouadio, Alain-Claude and Sena, Ghislaine and Yededji, Sahinou-Yediga and Assi, Rodrigue and Bakayoko, Alima and Mahassadi, Alassane and Attia, Alain and Oussou, Armel and Mobio, Max and Bamba, Doféré and Koman, Mesmin and Horo, Apollinaire and Deschamps, Nina and Chenal, Henri and Sassan-Morokro, Madeleine and Konate, Seidou and Aka, Kakou and Aoussi, Eba and Journot, Valérie and Nchot, Célestin and Karcher, Sophie and Chaix, Marie-Laure and Rouzioux, Christine and Sow, Papa-Salif and Perronne, Christian and Girard, Pierre-Marie and Menan, Hervé and Bissagnene, Emmanuel and Kadio, Auguste and Ettiegne-Traore, Virginie and Moh-Semdé, Corinne and Kouame, Abo and Massumbuko, Jean-Marie and Chêne, Geneviève and Dosso, Mireille and Domoua, Serge K and N'Dri-Yoman, Thérèse and Salamon, Roger and Eholié, Serge P and Anglaret, Xavier and The TEMPRANO ANRS 12136 Study Group and TEMPRANO ANRS 12136 Study Group
The New England journal of medicine, ISSN 1533-4406, 08/2015, Volume 373, Issue 9, pp. 808 - 822
Journal Article
The Lancet (British edition), ISSN 0140-6736, 09/2012, Volume 380, Issue 9846, pp. 986 - 993
Journal Article
The European respiratory journal, ISSN 0903-1936, 04/2012, Volume 39, Issue 4, pp. 956 - 962
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 06/2012, Volume 56, Issue 6, pp. 3027 - 3031
Journal Article